CN115611714A - Star-shaped ether compound, electrolyte and lithium battery - Google Patents

Star-shaped ether compound, electrolyte and lithium battery Download PDF

Info

Publication number
CN115611714A
CN115611714A CN202110734841.5A CN202110734841A CN115611714A CN 115611714 A CN115611714 A CN 115611714A CN 202110734841 A CN202110734841 A CN 202110734841A CN 115611714 A CN115611714 A CN 115611714A
Authority
CN
China
Prior art keywords
substituted
lithium
ether
star
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110734841.5A
Other languages
Chinese (zh)
Inventor
陈嵩
郭姿珠
马永军
谢静
袁涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BYD Co Ltd
Original Assignee
BYD Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BYD Co Ltd filed Critical BYD Co Ltd
Priority to CN202110734841.5A priority Critical patent/CN115611714A/en
Publication of CN115611714A publication Critical patent/CN115611714A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04Saturated ethers
    • C07C43/12Saturated ethers containing halogen
    • C07C43/126Saturated ethers containing halogen having more than one ether bond
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/052Li-accumulators
    • H01M10/0525Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodes; Lithium-ion batteries
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/056Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes
    • H01M10/0564Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes the electrolyte being constituted of organic materials only
    • H01M10/0566Liquid materials
    • H01M10/0567Liquid materials characterised by the additives
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/42Methods or arrangements for servicing or maintenance of secondary cells or secondary half-cells
    • H01M10/4235Safety or regulating additives or arrangements in electrodes, separators or electrolyte
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M2300/00Electrolytes
    • H01M2300/0017Non-aqueous electrolytes
    • H01M2300/0025Organic electrolyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/10Energy storage using batteries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Secondary Cells (AREA)

Abstract

The application provides a star-shaped ether compound, an electrolyte and a lithium battery, wherein the star-shaped ether compound has the following structural formula:

Description

Star-shaped ether compound, electrolyte and lithium battery
Technical Field
The application relates to the technical field of lithium batteries, in particular to a star-shaped ether compound, electrolyte and a lithium battery.
Background
The lithium metal has a low density(0.59g/cm 3 ) High theoretical specific capacity (3860 mAh/g) and low reduction potential (-3.04Vvs + /H 2 ) The lithium ion battery is considered as an ideal anode material of the next generation lithium battery, but has some problems in the using process: on one hand, lithium ions are continuously deposited on the surface of lithium metal in charge-discharge circulation, and the concentration gradient of local lithium ions causes different liquid-phase mass transfer flow, so that lithium dendrites are generated, and the problems of short circuit and the like are finally caused; on the other hand, lithium dendrites protruding from the surface of the negative electrode continuously grow due to the uneven deposition of lithium ions on the surface of lithium metal during charge and discharge cycles, resulting in the generation of "dead lithium" and reducing the capacity of the negative electrode.
Thus, the related art of the present lithium battery still needs to be improved.
Content of application
The present application is directed to solving, at least to some extent, one of the technical problems in the related art. Therefore, the application aims to provide a star-shaped ether compound, an electrolyte and a lithium battery.
In one aspect of the present application, a star ether compound is provided. According to embodiments of the present application, the star ether compounds have the following structural formula:
Figure BDA0003141221040000011
wherein X 1 、X 2 、X 3 Each independently is a bond or- (CH) 2 ) a -;
R 4 Is H or- (CH) 2 ) b -O-R 5
R 1 、R 2 、R 3 And R 5 Each independently selected from the group consisting of substituted or unsubstituted alkyl, substituted or unsubstituted haloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted halophenyl, substituted or unsubstituted benzyl, and substituted or unsubstituted halobenzyl;
the substituents in the substituted alkyl, substituted haloalkyl, substituted phenyl, substituted halophenyl, substituted benzyl and substituted halobenzyl groups are each independently selected from the group consisting of alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxy-substituted alkoxy, alkoxy-substituted haloalkoxy, haloalkoxy-substituted alkoxy, haloalkoxy-substituted haloalkoxy, acyl, cyanoalkoxy and cyano;
wherein R is 1 、R 2 、R 3 And R 5 Contains halogen, the halogen comprises at least one of fluorine, chlorine, bromine and iodine, a is an integer of 0 to 10, and b is an integer of 0 to 10.
The star-shaped ether compound has the characteristics of easiness in preparation and storage, non-flammability and industrialization potential, and when the star-shaped ether compound is used for an electrolyte, the star-shaped molecular structure can reduce intermolecular acting force, optimize the solvation structure and degree in the electrolyte, further reduce the viscosity of the electrolyte, and increase the wettability of the electrolyte on a pole piece; when the electrolyte is used for a lithium battery, lithium ions can rapidly move to a negative electrode, and the lithium ions are uniformly released on the surface of the negative electrode and deposited, so that the safety problem caused by the growth of lithium dendrites is solved; meanwhile, the electrolyte is beneficial to forming compact complex clusters between lithium ions in the electrolyte and a solvent, and can be uniformly distributed on the surface of a negative electrode under the action of an electric field during charging, so that a uniform and compact SEI (solid electrolyte interphase) film can be formed on the surface of the negative electrode, and the electrolyte also has high stability, wettability and safety on a positive electrode.
In another aspect of the present application, an electrolyte is provided. According to an embodiment of the application, the electrolyte comprises: a lithium salt; an organic solvent; and the star ether compounds described above. In the electrolyte, the star-shaped ether compound is added, so that the intermolecular acting force can be reduced, the solvation structure is optimized, the viscosity of the electrolyte is reduced, and the wettability of the electrolyte on a pole piece is improved; when the lithium ion battery is used for a lithium battery, lithium ions can rapidly move to the negative electrode, and the lithium ions are uniformly released and deposited on the surface of the negative electrode, so that the safety problem caused by the growth of lithium dendrites is solved; and lithium ions in the electrolyte can form a compact complex cluster with a solvent, and can be uniformly distributed on the surface of the negative electrode under the action of an electric field during charging, so that a uniform and compact SEI (solid electrolyte interphase) film can be formed on the surface of the negative electrode, and the electrolyte can also have high stability, wettability and safety for the positive electrode.
In yet another aspect of the present application, a lithium battery is provided. According to an embodiment of the present application, the lithium battery includes: a positive electrode; a negative electrode; a separator between the positive electrode and the negative electrode; at least a portion of the aforementioned electrolyte, the positive electrode, the negative electrode, and the separator is immersed in the electrolyte. The lithium battery has long cycle life and high safety, and the star-shaped ether compound is added in the adopted electrolyte, so that the limit on the anode material is small, besides low-potential lithium iron phosphate, the anode material with higher potential (such as lithium cobaltate, ternary anode material and the like) can also be used, and the application range is wider.
Drawings
FIG. 1 is a graph showing the results of a cycle performance test of the battery of example 23.
FIG. 2 is a graph showing the results of the cycle performance test of the battery of example 30.
FIG. 3 is a graph showing the results of the cycle performance test of the battery of example 36.
Fig. 4 is a graph showing the results of the cycle performance test of the battery of example 40.
Fig. 5 is a graph showing the results of the cycle performance test of the battery of example 43.
Fig. 6 is a graph showing the results of cycle performance tests of the battery in comparative example 1.
Fig. 7 is a graph of the coulombic efficiency test results for the battery of example 28.
Fig. 8 is a graph of coulombic efficiency test results for the cells of example 36.
Fig. 9 is a graph showing the results of coulombic efficiency tests on the cells of example 37.
Detailed Description
Embodiments of the present application are described in detail below. The following embodiments are described as illustrative only and are not to be construed as limiting the present application. The examples, where specific techniques or conditions are not indicated, are to be construed according to the techniques or conditions described in the literature in the art or according to the product specifications. The reagents or instruments used are conventional products which are commercially available, and are not indicated by manufacturers.
In one aspect of the present application, a star ether compound is provided. According to embodiments of the present application, the star ether compounds have the following structural formula:
Figure BDA0003141221040000031
wherein, X 1 、X 2 、X 3 Each independently is a bond or- (CH) 2 ) a -;
R 4 Is H and is- (CH) 2 ) b -O-R 5
R 1 、R 2 、R 3 And R 5 Each independently selected from the group consisting of substituted or unsubstituted alkyl, substituted or unsubstituted haloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted halophenyl, substituted or unsubstituted benzyl, and substituted or unsubstituted halobenzyl;
the substituents in the above substituted alkyl, substituted haloalkyl, substituted phenyl, substituted halophenyl, substituted benzyl and substituted halobenzyl are each independently selected from the group consisting of alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxy-substituted alkoxy, alkoxy-substituted haloalkoxy, haloalkoxy-substituted alkoxy, haloalkoxy-substituted haloalkoxy, acyl, cyanoalkoxy and cyano;
wherein R is 1 、R 2 、R 3 And R 5 Contains halogen, the halogen comprises at least one of fluorine, chlorine, bromine and iodine, a is an integer of 0 to 10, and b is an integer of 0 to 10.
The star-shaped ether compound has the characteristics of easiness in preparation and storage, non-flammability and industrialization potential, and when the star-shaped ether compound is used for an electrolyte, the star-shaped molecular structure can reduce intermolecular acting force, optimize the solvation structure and degree in the electrolyte, further reduce the viscosity of the electrolyte, and increase the wettability of the electrolyte on a pole piece; when the electrolyte is used for a lithium battery, lithium ions can rapidly move to a negative electrode, and the lithium ions are uniformly released on the surface of the negative electrode and deposited, so that the safety problem caused by the growth of lithium dendrites is solved; meanwhile, the electrolyte is beneficial to forming compact complex clusters between lithium ions in the electrolyte and a solvent, and can be uniformly distributed on the surface of a negative electrode under the action of an electric field during charging, so that a uniform and compact SEI (solid electrolyte interphase) film can be formed on the surface of the negative electrode, and the electrolyte can also have high stability, wettability and safety on a positive electrode.
It is to be understood that the specific meanings of certain descriptive terms and terms used herein are as follows:
when a =0, X is 1 、X 2 Or X 3 Is a chemical bond, O and C are directly connected to each other, to
Figure BDA0003141221040000041
For example, when a =0,
Figure BDA0003141221040000042
the actual structure is
Figure BDA0003141221040000043
b =0, - (CH) 2 ) b -O-R 5 Has the actual structure of-O-R 5
In each substituent and group
Figure BDA0003141221040000044
Represents a molecular chain linked to the corresponding position in each substituent and group, "-" in each substituent and group represents a position linked to other groups.
"substituted or unsubstituted alkyl" refers to unsubstituted alkyl (-C) n H 2n+1 N is a positive integer) or at least one HAlkyl (-C) substituted by a substituent R n H m R p P is a positive integer, m is a natural number, and m + p =2n + 1).
Substituted or unsubstituted phenyl means unsubstituted phenyl (
Figure BDA0003141221040000045
-C 6 H 5 ) Or phenyl (-C) in which at least one H is substituted by a substituent R 6 H c R d D is a positive integer, c is a natural number, and c + d = 5). Here, it is to be noted that 6 H c R d The 6 carbon atoms shown in (a) do not include carbon atoms in the substituent R.
Substituted or unsubstituted benzyl means an unsubstituted benzyl group (
Figure BDA0003141221040000046
-C 7 H 7 ) Or benzyl (-C) with at least one H substituted by a substituent R 7 H e R f Is a positive integer, e is a natural number, and e + f = 7). Here, it is to be noted that-C 7 H e R f The 7 carbon atoms shown in (a) do not include carbon atoms in the substituent R.
"haloalkyl" refers to an alkyl (-C) group in which at least one H is substituted with a halogen n H m Y q Y is halogen, q is a positive integer, m + q =2n +1, "substituted or unsubstituted haloalkyl" means haloalkyl (i.e., unsubstituted haloalkyl), or haloalkyl (-C) wherein at least one H is substituted with a substituent R n H m R p Y q M + p + q =2n + 1) (i.e., substituted haloalkyl).
"Halophenyl" refers to a phenyl group (-C) wherein at least one H is substituted with a halogen 6 H c Y g G is a positive integer, and C + g = 5), "substituted or unsubstituted halophenyl" refers to a halophenyl group (i.e., unsubstituted halophenyl group), or a halophenyl group (-C) in which at least one H is substituted with a substituent R 6 H c R d Y g C + d + g = 5) (i.e., substituted halophenyl). Here, it is to be noted that-C 6 H c R d Y g The 6 carbon atoms shown in (a) do not include carbon atoms in the substituent R.
"halobenzyl" means a benzyl group (-C) having at least one H substituted with a halogen 7 H e Y h H is a positive integer, and e + H = 7), "substituted or unsubstituted halobenzyl" refers to halobenzyl (i.e., unsubstituted halobenzyl), or halobenzyl (-C) wherein at least one H is substituted with a substituent R 7 H e R f Y h E + f + h = 7) (i.e. substituted halobenzyl). Here, it is to be noted that-C 7 H e R f Y h The 7 carbon atoms shown in (a) do not include carbon atoms in the substituent R.
"alkoxy" means-OC i H 2i+1 And i is a positive integer.
"haloalkoxy" means an alkoxy group (-OC) in which at least one H is substituted by halogen i H j Y k K is a positive integer, j + k =2i + 1).
"alkoxy-substituted alkoxy" refers to an alkoxy group (-OC) wherein at least one H is substituted by an alkoxy group i H j Z r Z is-OC i H 2i+1 R is a positive integer, j + r =2i + 1)
"cyano" means-CN.
"cyanoalkoxy" refers to an alkoxy group (-OC) wherein at least one H is replaced by a cyano group i H j W l W is-CN, l is a positive integer, j + l =2i + 1).
"acyl" refers to
Figure BDA0003141221040000051
Ra is H or alkyl.
“R 1 、R 2 、R 3 And R 5 Independently represents 8230, or R 1 、R 2 、R 3 And R 5 The groups (b) may be the same or different, and may be selected from the group defined in the present application.
The above substituents R are each independently an alkyl group, a haloalkyl group, an alkoxy group, a haloalkoxy group, an alkoxy-substituted alkoxy group, an alkoxy-substituted haloalkoxy group, a haloalkoxy-substituted alkoxy group, a haloalkoxy-substituted haloalkoxy group, an acyl group, a cyanoalkoxy group, and a cyano group.
According to embodiments of the present application, R 1 、R 2 、R 3 And R 5 Each independently selected from substituted or unsubstituted C 1-6 Alkyl, substituted or unsubstituted C 1-6 A haloalkyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted halophenyl group, a substituted or unsubstituted benzyl group, and a substituted or unsubstituted halobenzyl group; c substituted as described above 1-6 Alkyl, substituted C 1-6 The substituents in haloalkyl, substituted phenyl, substituted halophenyl, substituted benzyl and substituted halobenzyl are each independently selected from C 1-6 Alkyl radical, C 1-6 Haloalkyl, C 1-6 Alkoxy radical, C 1-6 Haloalkoxy, C 1-6 Alkoxy-substituted C 1-6 Alkoxy radical, C 1-6 Alkoxy-substituted C 1-6 Haloalkoxy, C 1-6 Haloalkoxy substituted C 1-6 Alkoxy radical, C 1-6 Haloalkoxy substituted C 1-6 Haloalkoxy, C 1-6 Acyl radical, C 1-6 Cyanoalkoxy and cyano, a is an integer from 0 to 6, and b is an integer from 0 to 6.
According to embodiments of the present application, R 1 、R 2 、R 3 And R 5 Each independently selected from C 1-6 Fluoroalkyl, C 1-4 Alkoxy-substituted C 1-4 Alkyl radical, C 1-4 Fluoroalkoxy-substituted C 1-4 Alkyl radical, C 1-4 Fluoroalkoxy-substituted C 1-4 Fluoroalkyl, C 1-4 Cyanoalkoxy-substituted C 1-4 Alkyl radical, C 1-4 Cyanoalkoxy-substituted C 1-4 Fluoroalkyl, fluorophenyl, C 1-4 Fluoroalkyl-substituted phenyl, C 1-4 Fluoroalkyl substituted benzyl, first substituent substituted C 1-4 Alkyl and C substituted by a first substituent 1-4 A fluoroalkyl group; wherein the first substituent is C 1-4 Fluoroalkoxy-substituted C 1-4 Alkoxy radical, C 1-4 Fluoroalkoxy-substituted C 1-4 Fluoroalkoxy radical, C 1-4 Alkoxy-substituted C 1-4 Fluoroalkoxy and C 1-4 Alkoxy-substituted C 1-4 Alkoxy, a is an integer of 0 to 2, and b is an integer of 0 to 2.
In addition, "C" above 1-4 "and" C 1-6 "refers to the number of carbon atoms in a group, e.g. C 1-4 The alkyl group is an alkyl group having 1 to 4 carbon atoms, and specifically may be a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group or a tert-butyl group, and C 1-6 The alkyl refers to an alkyl group having 1 to 6 carbon atoms, and other similar description meanings are the same as above, and redundant description thereof is omitted.
According to embodiments herein, the halogen may be fluorine. Therefore, the star ether compound can improve the stability of a positive electrode material at a positive electrode terminal, and can form a stable, compact, high-mechanical-strength and high-surface-energy lithium fluoride-rich SEI layer at a negative electrode terminal. Compared with the fluoroether in the related technology, the fluorine substitution in the star-shaped ether compound has the characteristics of higher modifiability and higher fluorination degree, and the ratio of C-H bonds in the star-shaped ether compound can be further reduced, so that the safety of the electrolyte is improved. Meanwhile, the star-shaped ether compound can be subjected to fluorination modification in different degrees according to different solvent strategies, so that the star-shaped ether compound has better electrochemical performance, and a CEI layer and an SEI layer rich in LiF are easier to form.
According to some embodiments of the application, R 1 、R 2 、R 3 And R 5 Each independently selected from the group consisting of:
Figure BDA0003141221040000061
according to the embodiments of the present application, the degree of halogen substitution of the star-shaped ether compound can be flexibly adjusted according to the use requirement, specifically, a part of H in the star-shaped ether compound may be substituted by halogen, or all H in the star-shaped compound may be substituted by halogen. In some embodiments, R 1 、R 2 And R 3 In each case containing the halogen or R 1 、R 2 、R 3 And R 5 All contain the halogen. The chemical structures of the chains in the star ether compounds can be the same or different, and in some specific embodiments, R is 1 、R 2 And R 3 Are the same radicals or R 1 、R 2 、R 3 And R 5 Are the same group. Specifically, the halogen content in the star-shaped compound is increased within a certain range, so that an SEI film can be formed more favorably, and the service performance of a lithium battery is further improved; and R is 1 、R 2 And R 3 Are the same radicals or R 1 、R 2 、R 3 And R 5 The star-shaped compound has a symmetrical structure due to the same groups, and is convenient to prepare while having a better using effect.
According to some embodiments of the application, X 1 、X 2 、X 3 Each independently is- (CH) 2 ) a -, and R 4 Is H, wherein a is 0, 1 or 2. According to other embodiments of the present application, X 1 、X 2 、X 3 Each independently is- (CH) 2 ) a -, and R 4 Is- (CH) 2 ) b -O-R 5 Wherein a is 1 or 2, b is 0, 1 or 2. Therefore, the star ether compound has better use effect and is easier to prepare.
According to some specific examples of the present application, the star ether-based compound includes at least one of:
Figure BDA0003141221040000071
Figure BDA0003141221040000081
in another aspect of the present application, there is provided a method for preparing the star ether compounds as described above. According to an embodiment of the application, the method comprises: mixing substance A and substanceB reaction to obtain star ether compound
Figure BDA0003141221040000082
Wherein substance A is selected from
Figure BDA0003141221040000083
Substance B is selected from R 1 -Y 1 、R 2 -Y 2 、R 3 -Y 3 And R 5 -Y 5 Wherein, Z 1 、Z 2 、Z 3 And Z 4 is-OH and Y 1 、Y 2 、Y 3 And Y 5 Each independently selected from halogen and-OTs (p-toluenesulfonyloxy) or Z 1 、Z 2 、Z 3 And Z 4 Is halogen and Y 1 、Y 2 、Y 3 And Y 5 Each independently selected from-ONa or-OTs (p-toluenesulfonyloxy); x 1 、X 2 、X 3 、R 1 、R 2 、R 3 、R 4 And R 5 And b are identical to the previous definitions and will not be described in detail herein.
According to some embodiments of the application, the method may be performed by at least one of the following synthetic routes:
Figure BDA0003141221040000084
Figure BDA0003141221040000091
specifically, when R is 4 When is H, can be
Figure BDA0003141221040000092
And R 1 -Y 1 、R 2 -Y 2 And R 3 -Y 3 Reacting to obtain a product
Figure BDA0003141221040000093
When R is 4 Is- (CH) 2 ) b -O-R 5 In time, can make
Figure BDA0003141221040000094
And R 1 -Y 1 、R 2 -Y 2 、R 3 --Y 3 And R 5 -Y 5 Reacting to obtain a product
Figure BDA0003141221040000095
In some embodiments, R 1 、R 2 、R 3 And R 5 Are different groups, in which case the reaction can be carried out stepwise, to
Figure BDA0003141221040000096
For purposes of illustration, R 1 -Y 1 、R 2 -Y 2 、R 3 -Y 3 And R 5 -Y 5 Can be stepped with
Figure BDA0003141221040000097
The reaction, the specific reaction sequence is not particularly limited and may be adjusted according to the actual circumstances, and wherein Y 1 、Y 2 、Y 3 And Y 5 May be the same or different. In other embodiments, R 1 、R 2 、R 3 And R 5 The same groups, in which case the above reaction can be carried out in one step or in steps as required, and in some embodiments, Y 1 、Y 2 、Y 3 And Y 5 Are also identical radicals, it being possible thereby for
Figure BDA0003141221040000101
Reacting with a substance (e.g. R) 1 -Y 1 ) Can obtain
Figure BDA0003141221040000102
The steps are simpler. In other embodiments, R 1 、R 2 、R 3 And R 5 Partially identical radicalsMoieties being different radicals, with R 1 、R 2 、R 3 Are identical radicals, R 5 And R 1 、R 2 、R 3 Different as an example, R 1 -Y 1 、R 2 -Y 2 、R 3 -Y 3 Can be combined with
Figure BDA0003141221040000103
Firstly, carrying out one-step reaction, then obtaining an intermediate product, and reacting the intermediate product with R 5 -Y 5 Reaction, wherein Y 1 、Y 2 、Y 3 Are identical radicals, and Y 5 Can be reacted with Y 1 、Y 2 、Y 3 The same or different.
Wherein, the reaction between-OH and halogen and-OTs (p-toluenesulfonyloxy), and the reaction between halogen and-ONa or-OTs (p-toluenesulfonyloxy) are classical acid-base reactions, and the specific reaction conditions may be selected according to practical situations, for example, the reaction may be performed by referring to conventional techniques, and are not described herein again.
In another aspect of the present application, an electrolyte is provided. According to an embodiment of the application, the electrolyte comprises: a lithium salt; an organic solvent; and the star ether compounds mentioned above. In the electrolyte, the star-shaped ether compound is added, so that the intermolecular acting force can be reduced, the solvation structure is optimized, the viscosity of the electrolyte is reduced, and the wettability of the electrolyte on a pole piece is improved; when the lithium ion battery is used for a lithium battery, lithium ions can rapidly move to the negative electrode, and the lithium ions are uniformly released and deposited on the surface of the negative electrode, so that the safety problem caused by the growth of lithium dendrites is solved; and lithium ions in the electrolyte can form a compact complex cluster with a solvent, and can be uniformly distributed on the surface of the negative electrode under the action of an electric field during charging, so that a uniform and compact SEI (solid electrolyte interphase) film can be formed on the surface of the negative electrode, and the electrolyte can also have high stability, wettability and safety for the positive electrode.
According to an embodiment of the present application, the lithium salt may be selected from a lithium phosphate, a lithium borate, a lithium boron group clusterAt least one of a compound, an imide salt of lithium, an aluminate salt of lithium, a heterocyclic anion salt of lithium, a halate salt of lithium, a sulfonate salt of lithium, and derivatives thereof. In some embodiments, the lithium salt is selected from lithium trifluoromethanesulfonate (LiTFA), lithium bistrifluoromethylsulfonimide (LiTFSI), lithium bistrifluorosulfonimide (LiFSI), lithium hexafluorophosphate (LiPF) 6 ) Lithium hexafluoroarsenate (LiAsF) 6 ) Lithium difluorophosphate (LiPOF) 2 ) Lithium tetrafluoroborate (LiBF) 4 ) Lithium difluoroborate (LiODFB), lithium dioxalate borate (LiBOB), lithium perchlorate (LiClO) 4 ) At least one of (1).
According to an embodiment of the present application, the organic solvent includes an ether compound or an ester compound. Specifically, in some embodiments, the organic solvent in the electrolyte is an ether compound. In other embodiments, the organic solvent in the electrolyte is an ester compound. The electrolyte is suitable for lithium or lithium-based alloy cathode batteries.
According to an embodiment of the present application, the ether compound includes at least one of a cyclic ether, a linear ether, and a fluorinated ether. Specifically, the ether compound may be composed of a cyclic ether, a linear ether, a fluorinated ether, a linear ether and a cyclic ether, a linear ether and a fluorinated ether, a cyclic ether and a fluorinated ether, or a cyclic ether, a linear ether and a fluorinated ether.
In some embodiments, the cyclic ether comprises at least one of 1, 3-dioxolane, 1, 4-dioxane, tetrahydrofuran, tetrahydropyran, and propylene oxide.
In some embodiments, the linear ether comprises at least one of methyl glycol dimethyl ether, methyl glycol diethyl ether, ethylene glycol dimethyl ether (DME), ethylene glycol diethyl ether, ethylene glycol methyl ethyl ether, t-butyl methyl ether, t-butyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetraethylene glycol dimethyl ether and dipropylene glycol dimethyl ether.
<xnotran> , -2,2- (BTFE), 1,1,1,2,3,3- -2,2,2- ,1,1,2,2- -2,2,3,3- ,1,1,2,2- -2,2,2- , , , ,1,1,1,2,2,3,3,4,4- , -1,1,2,2- ,2,2,3,3,3- ,2,2,3,3,3- ,1,1,2,3,3,3- ,1,1,2,2- ,1,1,2,2- ,1,1,1,1 ',1',1',2- ,2,2,3,3- , ,1,1,2,3,3,3- , (2,2,2- ) ,1,1,2,2- -1H,1H,5H- ,1,1,2,2- . </xnotran>
According to the embodiment of the application, when the organic solvent comprises both the linear ether and the cyclic ether, the ratio of the linear ether and the cyclic ether can be flexibly adjusted according to application needs. In some embodiments, the volume ratio of the linear ether to the cyclic ether can be 1 to 5:5-9, specifically 1. In some embodiments, the volume ratio of the linear ether to the cyclic ether can be 1-2:2-3, specifically 1.
According to an embodiment of the present application, the ester compound includes at least one of a linear carbonate, a cyclic carbonate, and a phosphate ester.
In some embodiments, the cyclic carbonate includes at least one of ethylene carbonate, propylene carbonate, 1, 2-butylene carbonate, 2, 3-butylene carbonate, 1, 2-pentylene carbonate, 2, 3-pentylene carbonate, and vinylene carbonate, and halides thereof.
In some embodiments, the linear carbonate is selected from at least one of dimethyl carbonate, diethyl carbonate, dipropyl carbonate, ethyl methyl carbonate, and propyl methyl carbonate.
In some embodiments, the phosphate ester is selected from at least one of trimethylphosphine oxide, triethylphosphine oxide, tripropylphosphine oxide, triphenylphosphine oxide, diethyl methylphosphonate, dimethyl methylphosphonate, diphenyl methylphosphonate, bis (2, 2-trifluoroethyl) methylphosphonate, trimethyl phosphate, triethyl phosphate, tripropyl phosphate, and ethylmethylphenyl phosphate.
According to an embodiment of the present application, the organic solvent may further include at least one of an organic acid ester and a nitrile compound. Specifically, the organic acid ester comprises at least one of methyl acetate, ethyl acetate, propyl acetate, ethyl propionate, propyl propionate, methyl propionate, gamma-butyrolactone, gamma-valerolactone, gamma-caprolactone, delta-valerolactone and epsilon-caprolactone; the nitrile compound comprises at least one of acetonitrile, propionitrile, butyronitrile, valeronitrile, capronitrile, enanthonitrile, cyclopentanecarbonitrile, cyclohexanecarbonitrile, 2-fluorobenzonitrile, 4-fluorobenzonitrile, difluorobenzonitrile, trifluoropropionitrile, phenylacetonitrile, 2-fluorophenylacetonitrile and 4-fluorophenylacetonitrile.
According to the embodiment of the present application, the molar ratio of the lithium salt, the organic solvent and the star-like ether compound is 1 to 1.5, 0.01 to 3.5, specifically 1. Specifically, the specific dosage of the star ether compound can be flexibly adjusted according to actual conditions, and the star ether compound can be applied to various different conditions and batteries within the range, is wide in application range and has a good use effect.
In yet another aspect of the present application, a lithium battery is provided. According to an embodiment of the present application, the lithium battery includes: a positive electrode; a negative electrode; a separator between the positive electrode and the negative electrode; at least a part of the aforementioned electrolyte, the positive electrode, the negative electrode, and the separator is immersed in the electrolyte. The lithium battery has long cycle life and high safety, and the star-shaped ether compound is added in the adopted electrolyte, so that the limit on the anode material is small, besides low-potential lithium iron phosphate, the anode material with higher potential (such as lithium cobaltate, ternary anode material and the like) can also be used, and the application range is wider.
Embodiments of the present application are described in detail below.
Example 1
Preparation of tris (2, 3-tetrafluoropropyl) orthoformate (S1)
Figure BDA0003141221040000121
10ml of 2, 3-tetrafluoropropanol was added in the round-bottom flask, then 1g of sodium was cut into pieces and slowly added to the round-bottom flask and stirred at room temperature for 30min, then freshly distilled chloroform was added 1ml and stirred at room temperature for 1h, finally heated to 50 ℃ and stirred for 48h, and the tris (2, 3-tetrafluoropropyl) orthoformate (S1) was obtained by distillation in 78% yield.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.46(s,3H),3.67(s,6H),5.10(s,1H).
example 2
Preparation of fluoroalkane-substituted 1,2, 4-butanetriol (S2)
Figure BDA0003141221040000131
1, 2-tetrafluoroiodoethane (4 eqv.) and 1,2, 4-butanetriol (1 eqv.) are added into a round-bottom flask for mixing, then excessive potassium carbonate and a catalytic amount of potassium iodide are added, then a DMF solvent is added, argon gas is introduced into the mixed solution for 15min, and then the reaction is heated to 70 ℃ under the protection of argon gas for 48h. And washing, extracting and distilling the reacted solution under reduced pressure to obtain S2 with the yield of 63%.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.52(s,3H),3.60(s,1H),3.40(m,2H),3.37(m,2H),1.64(q,2H).
example 3
Preparation of fluoroalkane-substituted 1,2, 4-butanetriol (S3)
Figure BDA0003141221040000132
2,2,3,3-tetrafluoropropanol (10 eq v.) was added in the round-bottom flask, then sodium (1 eq v.) was cut into pieces and slowly added to the round-bottom flask with stirring at room temperature for 30min, followed by addition of freshly distilled chloroform (0.4 eq v.) with stirring at room temperature for 24h, and distillation yielded an intermediate 5-chloro-1,1,2,2,8,8,9,9-octafluoro-3,5-heptanediol with a yield of 57%. Then the product is added into a propanol solution containing sodium propoxide, heated to 50 ℃ for reaction for 48 hours, washed with water and distilled to obtain the product S3 with the yield of 80%.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.46(s,2H),5.55(s,1H),3.69(s,4H),3.55(t,4H),3.4(s,3H)
example 4
Preparation of Compound S4
Synthetic procedure the procedure of reference example 2 was followed, starting materials used
Figure BDA0003141221040000133
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.02(s,3H),3.42(t,6H),1.38(dd,6H),1.20(dd,1H).
example 5
Preparation of Compound S5
Synthesis procedure referring to the procedure in example 3, starting materials carbon tetraiodide and 1, 2-tetrafluoroethanol were first reacted to give an intermediate product
Figure BDA0003141221040000141
Followed by
Figure BDA0003141221040000142
The reaction gives the compound S5.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.02(s,3H),5.48(t,1H),3.86(s,2H),3.73(d,2H).
example 6
Preparation of Compound S6
Figure BDA0003141221040000143
1, 2-tetrafluoroiodoethane (4 eq v.) and pentaerythritol (1 eq v.) were added in a round bottom flask, mixed by adding a small amount of dry DMF, then added with an excess of potassium carbonate and a catalytic amount of potassium iodide, followed by DMF solvent, and the mixed solution was purged with argon for 15min, followed by reaction under argon atmosphere and heating to 70 ℃ for 18h. And washing, extracting and distilling the reacted solution under reduced pressure to obtain an intermediate product with the yield of 43 percent. Then the intermediate product obtained in the previous step reacts with 2-iodo-1, 2' -tetrafluoroethyl ether in DMF added with potassium carbonate to obtain compound S6 with 82% yield.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.52(s,3H),5.48(t,1H),3.86(s,2H),3.73(d,2H),3.42(m,8H).
example 7
Preparation of Compound S7
Synthesis procedure the procedure of example 2 was referenced, starting material used
Figure BDA0003141221040000144
Figure BDA0003141221040000145
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.46(s,2H),5.55(s,1H),4.49(s,2H),3.67(d,4H),3.54(t,4H).
example 8
Preparation of Compound S8
Synthesis procedure the procedure of example 2 was referenced, starting material used
Figure BDA0003141221040000151
Figure BDA0003141221040000152
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.46(s,2H),5.55(s,1H),4.49(s,2H),3.86(s,2H),3.67(t,4H).
example 9
Preparation of Compound S9
Figure BDA0003141221040000153
As shown in the figure, two raw materials, excessive potassium carbonate and a catalytic amount of potassium iodide are added into a round-bottom flask, then DMF solvent is added, argon gas is introduced into the mixed solution for 15min, and then the reaction is heated to 70 ℃ under the protection of argon gas for 48h. And washing the reacted solution with water, extracting, and separating by column chromatography to obtain the compound S9 with the yield of 58%.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.15~7.3(m,12H),3.38(dd,6H),2.4(m,1H).
example 10
Preparation of Compound S10
Figure BDA0003141221040000154
4- (tosyloxy) -fluorinated benzene (4 eq v.) and pentaerythritol (1 eq v.) were added to a round bottom flask and purged with argon for 15min, followed by addition of potassium carbonate (5 eq v.) and a catalytic amount of potassium iodide and heating to 70 ℃ for reaction for 48h, followed by water washing and extraction with dichloromethane to give a crude product, which was isolated by column chromatography to give the product tris (4-fluorophenyl) orthoformate (S9) in 45% yield.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.15~7.3(m,16H),5.92(dd,8H).
example 11
Preparation of Compound S11
Figure BDA0003141221040000161
4-Fluoroiodomethylbenzene (4 eq v.) and 1,2, 4-butanetriol (1 eq v.) were mixed in a round bottom flask, then excess potassium carbonate and catalytic amount of potassium iodide were added, DMF solvent was then added, argon gas was bubbled through the mixed solution for 15min, and then the reaction was warmed to 90 ℃ under argon protection for 48h. And washing the reacted solution with water, extracting, and separating by column chromatography to obtain the product compound S11 with a yield of 68%.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.10~7.42(m,12H),4.63(s,6H),3.60(d,2H),3.40(m,1H),3.35(m,2H),1.64(m,1H).
example 12
Preparation of Compound S12
Synthetic procedure with reference to the procedure in example 9, pentaerythritol and p-trifluoromethylbenzyl alcohol were used as starting materials.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.72(s,8H),4.63(s,8H),5.87(dd,8H).
example 13
Preparation of Compound S13
Synthetic procedure the procedure of reference example 9 was followed, starting from
Figure BDA0003141221040000162
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):3.98(dd,6H),3.05(m,1H).
example 14
Preparation of Compound S14
Synthesis procedure referring to the procedure in example 9, starting with pentaerythritol and p-iodofluorobenzene as starting materials, an intermediate product is obtained
Figure BDA0003141221040000163
Subsequently and
Figure BDA0003141221040000164
the reaction yielded compound S14.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.47(d,6H),6.79(d,6H),6.03(dd,2H),5.92(dd,6H).
example 15
Preparation of Compound S15
Synthetic procedure the procedure of reference example 9 was followed, starting from
Figure BDA0003141221040000171
And 4-iodotrifluoromethylbenzene.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.47(d,6H),6.79(d,6H),3.89(dd,6H),2.97(m,1H).
example 16
Preparation of Compound S16
Synthetic procedure with reference to the procedure in example 9, pentaerythritol and 2,4, 6-tris (trifluoromethyl) -iodobenzene were used as starting materials.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):7.53(s,8H),5.67(dd,8H).
example 17
Preparation of Compound S17
Synthetic procedure the procedure of reference example 3 was followed, starting materials used
Figure BDA0003141221040000172
And tribromomethane.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):3.52(t,12H),5.55(s,1H).
example 18
Preparation of Compound S18
Synthesis procedure the procedure of example 3 is referred to, starting materials used
Figure BDA0003141221040000173
And tribromomethane.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.51(s,3H),3.86(s,6H),5.10(s,1H).
example 19
Preparation of Compound S19
Synthetic procedure the procedure of reference example 3 was followed, starting materials used
Figure BDA0003141221040000174
And triiodomethane.
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):5.48(t,3H),3.73(d,6H),3.54(t,12H),5.24(s,1H).
example 20
Preparation of Compound S20
Synthesis procedure the procedure of example 3 is referred to, starting materials used
Figure BDA0003141221040000175
Nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):6.02(s,4H),3.37(t,8H),1.38(dd,8H).
example 21
Preparation of Compound S21
Synthesis procedure referring to the procedure in example 3, pentaerythritol and
Figure BDA0003141221040000181
nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):3.86(s,8H),3.29(s,8H).
example 22
Preparation of Compound S22
Synthesis procedure the procedure of reference example 3 is followed, starting with pentaerythritol and
Figure BDA0003141221040000182
nuclear magnetic resonance hydrogen spectrum of the product: 1 H NMR(400MHz,CDCl 3 )δ(ppm):5.55(t,4H),3.73(d,8H),3.58(t,16H),3.48(dd,8H).
examples 23 to 44 and comparative example 1
The formulations of the electrolytes of examples 23 to 30 are shown in table 1 below, the formulations of the electrolytes of examples 31 to 36 are shown in table 2 below, and the formulations of the electrolytes of examples 37 to 44 and comparative example 1 are shown in table 3 below.
TABLE 1
Figure BDA0003141221040000183
Figure BDA0003141221040000191
TABLE 2
Figure BDA0003141221040000192
TABLE 3
Figure BDA0003141221040000201
And (4) performance testing:
initial discharge capacity:
the electrolyte prepared as above was applied to a laminated battery as an electrolyte, and the electrochemical performance of the laminated battery was tested using a blue battery (test results are shown in tables 1 and 2). The laminated cell was charged and discharged between 3.0V and 4.4V using a rate of 0.05C (calculated as positive electrode) for the first cycle of lithium metal, and the capacity exerted by lithium cobaltate was calculated as the initial discharge capacity. For the subsequent charge and discharge cycles, a rate of 0.5C (calculated as positive electrode) was used. At the end of each 0.5C charge of the battery, a trickle current of 0.05C is used. Between each charge and discharge, it is the cell that is left open for 5 minutes.
The preparation method of the laminated battery comprises the following steps: to N-methyl-2-pyrrolidone (NMP) as a solvent, 98 wt% of lithium cobaltate as a positive electrode active material, 1 wt% of carbon black as a conductive agent, and 1 wt% of polyvinylidene fluoride (PVDF) as a binder were added to prepare a positive electrode slurry. The positive electrode slurry was coated on an aluminum (Al) current collector at a thickness of about 50 μm to form a positive electrode film, and dried and then rolled to prepare a positive electrode. Lithium metal was coated on a copper (Cu) thin film as an anode current collector in a thickness of about 25 μm, followed by completing the preparation of an anode using a roll press. The above positive electrode was cut into a positive electrode sheet of 44 × 23mm in size, the copper foil coated with lithium metal was cut into a negative electrode sheet of 45 × 24mm in size, a pouch battery was prepared by a lamination method using the prepared positive and negative electrodes and a separator composed of three layers of polypropylene/polyethylene/polypropylene (PP/PE/PP), and then the prepared electrolyte was injected into a battery pack to complete the preparation of a lithium battery.
The graphs of the cycle performance test results of the batteries of example 23, example 30, example 36, example 40 and example 43 are shown in fig. 1, fig. 2, fig. 3, fig. 4 and fig. 5, respectively, and the graph of the cycle performance test result of the battery of comparative example 1 is shown in fig. 6. According to the test results, the star-shaped ether compound is added into the ether-based or carbonate-based electrolyte in equal amount, so that the cycle performance and capacity exertion performance of the lithium battery are better, and the cycle stability is improved. Compared with the application of the carbonate-based electrolyte (comparative example 1) of the traditional lithium ion battery in the lithium battery, the star-shaped ether compound added into the ether-based or fluorine-ether-based electrolyte can obviously improve the cycle performance and capacity exertion of the lithium battery.
Coulomb efficiency:
the preparation method of the button cell comprises the following steps of cutting a 500-micron lithium sheet into a 16 pi-sized wafer, cutting a copper foil into a 17 pi-sized wafer, and cutting a three-layer diaphragm composed of polypropylene/polyethylene/polypropylene (PP/PE/PP) into a 19 pi-sized wafer, wherein the preparation method of the button cell comprises the following steps: and placing the diaphragm between the anode and the cathode, filling the prepared electrolyte system between the anode and the cathode, packaging and compacting, and assembling into the CR2032 type button battery.
The button cells prepared above were tested for electrochemical properties using a blue cell battery (test results are shown in tables 1 and 2). Discharging is carried out for 2 hours by using a current density (calculated according to the area of the negative electrode) of 2mA/ce, then charging is carried out to 1V by using a current density (calculated according to the area of the negative electrode) of 2mA/ce, then discharging is carried out for 2 hours by using a current density (calculated according to the area of the negative electrode) of 2mA/ce, charging and discharging cycles are respectively carried out for ten weeks by using a current density (calculated according to the area of the negative electrode) of 2mA/ce after certain lithium is deposited on the surface of the copper foil, the battery is charged to 1V by using a current density (calculated according to the area of the negative electrode) of 2mA/ce after the cycles are finished, and the coulomb efficiency of the electrolyte to lithium metal is calculated according to the capacity. The results of coulombic efficiency tests for the cells of example 28, example 36 and example 37 are shown in fig. 7, fig. 8 and fig. 9, respectively. According to the test results, the addition of the star-shaped ether compound in the electrolyte based on ether or fluorine ether improves the coulomb efficiency of the electrolyte provided by the application to lithium.
In the description herein, reference to the description of the term "one embodiment," "some embodiments," "an example," "a specific example," or "some examples," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the application. In this specification, the schematic representations of the terms used above are not necessarily intended to refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, various embodiments or examples and features of different embodiments or examples described in this specification can be combined and combined by one skilled in the art without contradiction.
While embodiments of the present application have been shown and described above, it will be understood that the above embodiments are exemplary and should not be construed as limiting the present application and that changes, modifications, substitutions and alterations in the above embodiments may be made by those of ordinary skill in the art within the scope of the present application.

Claims (14)

1. A star ether compound is characterized by having the following structural formula:
Figure FDA0003141221030000011
wherein, X 1 、X 2 、X 3 Each independently is- (CH) 2 ) a -;
R 4 Is H or- (CH) 2 ) b -O-R 5
R 1 、R 2 、R 3 And R 5 Each independently selected from substituted or unsubstituted alkyl, substituted or unsubstitutedUnsubstituted haloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted halophenyl, substituted or unsubstituted benzyl, and substituted or unsubstituted halobenzyl;
the substituents in the substituted alkyl, substituted haloalkyl, substituted phenyl, substituted halophenyl, substituted benzyl and substituted halobenzyl groups are each independently selected from the group consisting of alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxy-substituted alkoxy, alkoxy-substituted haloalkoxy, haloalkoxy-substituted alkoxy, haloalkoxy-substituted haloalkoxy, acyl, cyanoalkoxy and cyano;
wherein R is 1 、R 2 、R 3 And R 5 Contains a halogen including at least one of fluorine, chlorine, bromine and iodine;
a is an integer of 0 to 10, and b is an integer of 0 to 10.
2. The star ether compound according to claim 1, wherein,
R 1 、R 2 、R 3 and R 5 Each independently selected from substituted or unsubstituted C 1-6 Alkyl, substituted or unsubstituted C 1-6 Haloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted halophenyl, substituted or unsubstituted benzyl, and substituted or unsubstituted halobenzyl;
c substituted as described above 1-6 Alkyl, substituted C 1-6 The substituents in haloalkyl, substituted phenyl, substituted halophenyl, substituted benzyl and substituted halobenzyl are each independently selected from C 1-6 Alkyl radical, C 1-6 Haloalkyl, C 1-6 Alkoxy radical, C 1-6 Haloalkoxy, C 1-6 Alkoxy-substituted C 1-6 Alkoxy radical, C 1-6 Alkoxy-substituted C 1-6 Haloalkoxy, C 1-6 Haloalkoxy substituted C 1-6 Alkoxy radical, C 1-6 Haloalkoxy substituted C 1-6 Haloalkoxy, C 1-6 Acyl radical, C 1-6 Cyanoalkoxy and cyano;
a is an integer of 0 to 6, and b is an integer of 0 to 6.
3. The star ether compound according to claim 1, wherein the halogen is fluorine.
4. The star ether compound according to claim 1, wherein R is R 1 、R 2 、R 3 And R 5 Each independently selected from C 1-6 Fluoroalkyl, C 1-4 Alkoxy-substituted C 1-4 Alkyl radical, C 1-4 Fluoroalkoxy-substituted C 1-4 Alkyl radical, C 1-4 Fluoroalkoxy-substituted C 1-4 Fluoroalkyl, C 1-4 Cyanoalkoxy-substituted C 1-4 Alkyl radical, C 1-4 Cyanoalkoxy-substituted C 1-4 Fluoroalkyl, fluorophenyl, C 1-4 Fluoroalkyl-substituted phenyl, fluorobenzyl, C 1-4 Fluoroalkyl substituted benzyl, first substituent substituted C 1-4 Alkyl and C substituted by a first substituent 1-4 A fluoroalkyl group; wherein the first substituent is C 1-4 Fluoroalkoxy-substituted C 1-4 Alkoxy radical, C 1-4 Fluoroalkoxy-substituted C 1-4 Fluoroalkoxy radical, C 1-4 Alkoxy-substituted C 1-4 Fluoroalkoxy and C 1-4 Alkoxy-substituted C 1-4 An alkoxy group;
a is an integer of 0 to 2, and b is an integer of 0 to 2.
5. The star ether compound according to claim 1, wherein R is R 1 、R 2 、R 3 And R 5 Each independently selected from the group consisting of:
Figure FDA0003141221030000021
6. the star ether compound according to claim 1, wherein at least one of the following conditions is satisfied:
R 1 、R 2 and R 3 All containing the halogen;
R 1 、R 2 、R 3 and R 5 All containing the halogen;
R 1 、R 2 and R 3 Are the same group; and
R 1 、R 2 、R 3 and R 5 Are the same group.
7. The star ether compound according to any one of claims 1 to 6, wherein,
X 1 、X 2 、X 3 each independently is- (CH) 2 ) a -, and R 4 Is H, wherein a is 0, 1 or 2; or alternatively
X 1 、X 2 、X 3 Each independently is- (CH) 2 ) a -, and R 4 Is- (CH) 2 ) b -O-R 5 Wherein a is 1 or 2, b is 0, 1 or 2.
8. The star ether compound according to claim 1, comprising at least one of:
Figure FDA0003141221030000031
Figure FDA0003141221030000041
9. an electrolyte, comprising:
a lithium salt;
an organic solvent; and
the star ether compound according to any one of claims 1 to 8.
10. The electrolyte according to claim 9, wherein the molar ratio of the lithium salt, the organic solvent, and the star-shaped ether compound is 1 to 1.5.
11. The electrolyte of claim 9, wherein at least one of the following conditions is satisfied:
the lithium salt is selected from at least one of lithium phosphate, lithium borate, lithium boron cluster compound, lithium imide salt, lithium aluminate, lithium heterocyclic anion salt, lithium halide salt, lithium sulfonate and derivatives thereof;
the organic solvent comprises an ether compound or an ester compound;
wherein the ether compound comprises at least one of cyclic ether, linear ether and fluorinated ether;
the ester compound comprises at least one of linear carbonate, cyclic carbonate and phosphate.
12. The electrolyte of claim 11, wherein at least one of the following conditions is satisfied:
the lithium salt is selected from at least one of lithium trifluoromethanesulfonate, lithium bistrifluoromethylsulfonyl imide, lithium difluorosulfonyl imide, lithium hexafluorophosphate, lithium hexafluoroarsenate, lithium difluorophosphate, lithium tetrafluoroborate, lithium difluorooxalato borate, lithium dioxaoxalato borate and lithium perchlorate;
the ether compound comprises cyclic ether and linear ether, and the volume ratio of the linear ether to the cyclic ether is 1-5:5-9;
the cyclic ether comprises at least one of 1, 3-dioxolane, 1, 4-dioxane, tetrahydrofuran, tetrahydropyran, and propylene oxide;
the linear ether comprises at least one of methyl glycol dimethyl ether, methyl glycol diethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol methyl ethyl ether, tertiary butyl methyl ether, tertiary butyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetraethylene glycol dimethyl ether and dipropylene glycol dimethyl ether;
<xnotran> -2,2- ,1,1,1,2,3,3- -2,2,2- ,1,1,2,2- -2,2,3,3- ,1,1,2,2- -2,2,2- , , , ,1,1,1,2,2,3,3,4,4- , -1,1,2,2- ,2,2,3,3,3- ,2,2,3,3,3- ,1,1,2,3,3,3- ,1,1,2,2- ,1,1,2,2- ,1,1,1,1 ',1',1',2- ,2,2,3,3- , ,1,1,2,3,3,3- , (2,2,2- ) ,1,1,2,2- -1H,1H,5H- ,1,1,2,2- ; </xnotran>
The cyclic carbonate includes at least one of ethylene carbonate, propylene carbonate, 1, 2-butylene carbonate, 2, 3-butylene carbonate, 1, 2-pentylene carbonate, 2, 3-pentylene carbonate, and vinylene carbonate, and halides thereof;
the linear carbonate is selected from at least one of dimethyl carbonate, diethyl carbonate, dipropyl carbonate, methyl ethyl carbonate and methyl propyl carbonate;
the phosphate ester is selected from at least one of trimethylphosphine oxide, triethylphosphine oxide, tripropylphosphine oxide, triphenylphosphine oxide, diethyl methylphosphonate, dimethyl methylphosphonate, diphenyl methylphosphonate, bis (2, 2-trifluoroethyl) methylphosphonate, trimethyl phosphate, triethyl phosphate, tripropyl phosphate and ethyl methyl phenyl phosphate.
13. The electrolyte of claim 9, wherein the organic solvent further comprises at least one of an organic acid ester and a nitrile compound;
the organic acid ester comprises at least one of methyl acetate, ethyl acetate, propyl acetate, ethyl propionate, propyl propionate, methyl propionate, gamma-butyrolactone, gamma-valerolactone, gamma-caprolactone, delta-valerolactone and epsilon-caprolactone;
the nitrile compound comprises at least one of acetonitrile, propionitrile, butyronitrile, valeronitrile, hexanenitrile, heptanenitrile, cyclopentanecarbonitrile, cyclohexanecarbonitrile, 2-fluorobenzonitrile, 4-fluorobenzonitrile, difluorobenzonitrile, trifluorobenzonitrile, phenylacetonitrile, 2-fluorobenzonitrile and 4-fluorobenzonitrile.
14. A lithium battery, comprising:
a positive electrode;
a negative electrode;
a separator between the positive electrode and the negative electrode;
the electrolytic solution according to any one of claims 9 to 13, wherein at least a part of the positive electrode, the negative electrode, and the separator is immersed in the electrolytic solution.
CN202110734841.5A 2021-06-30 2021-06-30 Star-shaped ether compound, electrolyte and lithium battery Pending CN115611714A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110734841.5A CN115611714A (en) 2021-06-30 2021-06-30 Star-shaped ether compound, electrolyte and lithium battery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110734841.5A CN115611714A (en) 2021-06-30 2021-06-30 Star-shaped ether compound, electrolyte and lithium battery

Publications (1)

Publication Number Publication Date
CN115611714A true CN115611714A (en) 2023-01-17

Family

ID=84854447

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110734841.5A Pending CN115611714A (en) 2021-06-30 2021-06-30 Star-shaped ether compound, electrolyte and lithium battery

Country Status (1)

Country Link
CN (1) CN115611714A (en)

Similar Documents

Publication Publication Date Title
US11177507B2 (en) Electrolyte for lithium secondary battery and lithium secondary battery including the same
KR102498193B1 (en) Electrolyte for non-aqueous electrolyte battery and non-aqueous electrolyte battery using the same
CN110911752A (en) Low-internal-resistance lithium secondary battery electrolyte and lithium secondary battery
TWI449231B (en) Nonaqueous electrolyte
US20190067741A1 (en) Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Containing the Same
CN111433962A (en) Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same
JP6007994B2 (en) Non-aqueous electrolyte secondary battery electrolyte and non-aqueous electrolyte secondary battery using the same
WO2019117101A1 (en) Electrolyte solution for nonaqueous electrolyte batteries and nonaqueous electrolyte battery using same
WO2019111983A1 (en) Electrolyte solution for nonaqueous electrolyte batteries, and nonaqueous electrolyte battery using same
KR20200104772A (en) Compound, electrolyte for lithium secondary battery and lithium secondary battery including the same
CN111788732A (en) Lithium secondary battery electrolyte and lithium secondary battery comprising same
KR20160109664A (en) Organic electrolytic solution and Lithium battery comprising organic electrolyte solution
JP2000138071A (en) Nonaqueous electrolyte, and lithium secondary battery using the same
CN111883837A (en) Electrolyte containing cyclic pyrophosphate and lithium ion battery
CN111710910A (en) Electrolyte containing bis-tetrafluorophosphoryl imide salt and lithium ion battery
CN109119687B (en) Electrolyte and electrochemical energy storage device
CN112186254A (en) Electrolyte containing difluoro oxalic acid phosphorus imide lithium and lithium ion battery using electrolyte
CN115611714A (en) Star-shaped ether compound, electrolyte and lithium battery
CN114695960A (en) Novel additive with high and low temperature performance, preparation method and application thereof
JP2021125417A (en) Positive electrode active material precursor for secondary cell, positive electrode active material for secondary cell, catholyte for secondary cell, positive electrode for secondary cell and secondary cell
EP4156364B1 (en) Secondary battery electrolyte and lithium secondary battery including the same
KR102463257B1 (en) Electrolyte for lithium secondary battery and lithium secondary battery comprising the same
CN112186252B (en) Electrolyte containing lithium difluoromalonate phosphoryl imine and lithium ion battery using same
KR102467447B1 (en) Electrolyte for lithium secondary battery and lithium secondary battery comprising the same
CN109411813B (en) Electrolyte and electrochemical energy storage device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination